CytoDyn CYDY
OTC CYDY
$0.20 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

CytoDyn (CYDY) Asset Writedowns and Impairment (2020 - 2022)

Updated

CytoDyn (CYDY) recorded Asset Writedowns and Impairment of $20.63 million in FY2023 (year ended May 31, 2023), down 71.9% from $73.5 million in FY2022.

Analysis

CytoDyn (CYDY) Asset Writedowns and Impairment (2020 - 2022) Analysis & Trends

  • Per Business Quant data, CYDY's Asset Writedowns and Impairment was $73.5 million in FY2022 (+631.4%) and $10.05 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 CytoDyn 274.70 Mn 274.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2022 17.93 Mn
Aug 31, 2022 2.70 Mn
May 31, 2022 64.58 Mn
Feb 28, 2022 5.56 Mn
Nov 30, 2021 1.59 Mn
Aug 31, 2021 1.76 Mn
May 31, 2021 -4.75 Mn
Feb 28, 2021 10.00 Mn
Nov 30, 2020 4.80 Mn
API Access

CytoDyn Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=CYDY&period=max&api_key=YOUR_API_KEY